BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 33399658)

  • 1. [Clinical characteristics and microbiological profile of viridans group streptococci bacteremia in children with cancer and high-risk febrile neutropenia].
    Cortés D; Maldonado ME; Rivacoba MC; Maza V; Valenzuela R; Payá E; Contardo V; Álvarez AM; Avilés CL; Becker A; Salgado C; Tordecilla J; Varas M; Venegas M; Villarroel M; Viviani T; Zubieta M; Santolaya ME
    Rev Chilena Infectol; 2020 Aug; 37(4):383-388. PubMed ID: 33399658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Microorganisms isolated from blood cultures and resistance profile in children with cancer and high-risk febrile neutropenia. Red PINDA, Chile, 2016-2021].
    Valenzuela R; Riquelme C; de la Maza V; Álvarez AM; Contardo V; Ducasse K; Payá E; Claverie X; Venegas M; Santolaya ME
    Andes Pediatr; 2024 Apr; 95(2):143-150. PubMed ID: 38801361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viridans Group Streptococci in Pediatric Leukemia and Stem Cell Transplant: Review of a Risk-stratified Guideline for Empiric Vancomycin in Febrile Neutropenia.
    Ruhayel SD; Foley DA; Hamilton K; Ferguson P; Kotecha RS; Bowen AC; Yeoh DK
    Pediatr Infect Dis J; 2021 Sep; 40(9):832-834. PubMed ID: 34285167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pediatric Febrile Neutropenia: Change in Etiology of Bacteremia, Empiric Choice of Therapy and Clinical Outcomes.
    Alali M; David MZ; Danziger-Isakov LA; Elmuti L; Bhagat PH; Bartlett AH
    J Pediatr Hematol Oncol; 2020 Aug; 42(6):e445-e451. PubMed ID: 32404688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics and antibiotic susceptibility of viridans streptococcal bacteremia in children with febrile neutropenia.
    Han SB; Bae EY; Lee JW; Lee DG; Chung NG; Jeong DC; Cho B; Kang JH; Kim HK
    Infection; 2013 Oct; 41(5):917-24. PubMed ID: 23640200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of a clinical model to predict the presence of β-lactam resistance in viridans group streptococci causing bacteremia in neutropenic cancer patients.
    Shelburne SA; Lasky RE; Sahasrabhojane P; Tarrand JT; Rolston KV
    Clin Infect Dis; 2014 Jul; 59(2):223-30. PubMed ID: 24755857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viridans Group Streptococcal Infections in Children After Chemotherapy or Stem Cell Transplantation: A 10-year Review From a Tertiary Pediatric Hospital.
    Nielsen MJ; Claxton S; Pizer B; Lane S; Cooke RPD; Paulus S; Carrol ED
    Medicine (Baltimore); 2016 Mar; 95(9):e2952. PubMed ID: 26945409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors and outcomes of viridans group streptococcal infections in pediatric acute myeloid leukemia: from the Canadian infections in AML research group.
    Lewis V; Yanofsky R; Mitchell D; Dix D; Ethier MC; Gillmeister B; Johnston D; Michon B; Stobart K; Portwine C; Silva M; Cellot S; Price V; Bowes L; Zelcer S; Brossard J; Beyene J; Sung L
    Pediatr Infect Dis J; 2014 Feb; 33(2):126-9. PubMed ID: 24064558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bloodstream infections in children with cancer and high risk fever and neutropenia episodes in six hospitals of Santiago, Chile between 2004 and 2009].
    Solís Y; Álvarez AM; Fuentes D; de la Barra D; Avilés CL; Becker A; Salgado C; Silva P; Topelberg S; Tordecilla J; Varas M; Villarroel M; Viviani T; Zubieta M; Aedo S; Santolaya ME
    Rev Chilena Infectol; 2012 Apr; 29(2):156-62. PubMed ID: 22689029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breakthrough viridans streptococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients receiving levofloxacin prophylaxis in a Japanese hospital.
    Kimura M; Araoka H; Yoshida A; Yamamoto H; Abe M; Okamoto Y; Yuasa M; Kaji D; Kageyama K; Nishida A; Ishiwata K; Takagi S; Yamamoto G; Asano-Mori Y; Uchida N; Hishinuma A; Izutsu K; Wake A; Taniguchi S; Yoneyama A
    BMC Infect Dis; 2016 Aug; 16():372. PubMed ID: 27495798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viridans group streptococci bloodstream infections in neutropenic adult patients with hematologic malignancy: Single center experience.
    Radocha J; Paterová P; Zavřelová A; Víšek B; Gabalec F; Žemličková H; Žák P
    Folia Microbiol (Praha); 2018 Mar; 63(2):141-146. PubMed ID: 28776170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging Resistance Trends in Viridans Group Streptococci Bloodstream Infections Among Immunocompromised Children Receiving Levofloxacin Prophylaxis.
    Quintero AM; Cruz Vidal DA; Klamer BG; Ardura MI; Oyeniran SJ
    J Pediatric Infect Dis Soc; 2023 Jul; 12(7):381-391. PubMed ID: 37490409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic prophylaxis with teicoplanin on alternate days reduces rate of viridans sepsis and febrile neutropenia in pediatric patients with acute myeloid leukemia.
    Boztug H; Mühlegger N; Pötschger U; Attarbaschi A; Peters C; Mann G; Dworzak M
    Ann Hematol; 2017 Jan; 96(1):99-106. PubMed ID: 27699447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro inferiority of ceftazidime compared with other beta-lactams for viridans group Streptococcus bacteremia in pediatric oncology patients: implications for antibiotic choices.
    Paulus S; Dobson S; Rassekh S; Blondel-Hill E
    J Pediatr Hematol Oncol; 2009 Apr; 31(4):267-9. PubMed ID: 19346878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Characterization of episodes of febrile neutropenia in children with acute myeloid leukemia and acute lymphoblastic leukemia].
    Ducasse K; Fernández JP; Salgado C; Alvarez AM; Avilés CL; Becker A; Topelberg S; Tordecilla J; Varas M; Villarroel M; Viviani T; Zubieta M; Santolaya ME
    Rev Chilena Infectol; 2014 Jun; 31(3):333-8. PubMed ID: 25146209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High frequency of streptococcal bacteraemia during childhood AML therapy irrespective of dose of cytarabine.
    Johannsen KH; Handrup MM; Lausen B; Schrøder H; Hasle H
    Pediatr Blood Cancer; 2013 Jul; 60(7):1154-60. PubMed ID: 23281248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation with poor prognosis.
    Moghnieh R; Estaitieh N; Mugharbil A; Jisr T; Abdallah DI; Ziade F; Sinno L; Ibrahim A
    Front Cell Infect Microbiol; 2015; 5():11. PubMed ID: 25729741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three cases of viridans group streptococcal bacteremia in children with febrile neutropenia and literature review.
    Danilatou V; Mantadakis E; Galanakis E; Christidou A; Stiakaki E; Kalmanti M
    Scand J Infect Dis; 2003; 35(11-12):873-6. PubMed ID: 14723365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic susceptibility of Gram-negatives isolated from bacteremia in children with cancer. Implications for empirical therapy of febrile neutropenia.
    Castagnola E; Caviglia I; Pescetto L; Bagnasco F; Haupt R; Bandettini R
    Future Microbiol; 2015; 10(3):357-64. PubMed ID: 25812459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacteremia due to viridans streptococci that are highly resistant to penicillin: increase among neutropenic patients with cancer.
    Carratalá J; Alcaide F; Fernández-Sevilla A; Corbella X; Lińares J; Gudiol F
    Clin Infect Dis; 1995 May; 20(5):1169-73. PubMed ID: 7619995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.